{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:37:48Z","timestamp":1787161068968,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"DOI":"10.1007\/s10840-024-01842-7","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T15:00:39Z","timestamp":1719241239000},"page":"1877-1890","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Protocol modifications reduce risk of delayed pericardial effusions after vein of Marshall ethanol infusion: follow-up from the Maine experience"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8229-3326","authenticated-orcid":false,"given":"Jordan S.","family":"Leyton-Mange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda D.","family":"Haskell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Corsello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Black-Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward Y.","family":"Sze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry W.","family":"Sesselberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,24]]},"reference":[{"key":"1842_CR1","doi-asserted-by":"publisher","first-page":"f366","DOI":"10.1093\/europace\/eux297","volume":"20","author":"JA Clarnette","year":"2018","unstructured":"Clarnette JA, Brooks AG, Mahajan R, Elliott AD, Twomey DJ, Pathak RK, Kumar S, Munawar DA, Young GD, Kalman JM, Lau DH, Sanders P. Outcomes of persistent and long-standing persistent atrial fibrillation ablation: a systematic review and meta-analysis. Europace\u202f: European pacing, arrhythmias, and cardiac electrophysiology\u202f: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2018;20:f366\u201376.","journal-title":"Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology"},{"key":"1842_CR2","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1056\/NEJMoa1408288","volume":"372","author":"A Verma","year":"2015","unstructured":"Verma A, Jiang CY, Betts TR, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372:1812\u201322.","journal-title":"N Engl J Med"},{"key":"1842_CR3","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1001\/jama.2020.16195","volume":"324","author":"M Valderrabano","year":"2020","unstructured":"Valderrabano M, Peterson LE, Swarup V, et al. Effect of catheter ablation with vein of marshall ethanol infusion vs catheter ablation alone on persistent atrial fibrillation: the VENUS randomized clinical trial. JAMA. 2020;324:1620\u20138.","journal-title":"JAMA"},{"key":"1842_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/jce.13797","volume":"30","author":"T Pambrun","year":"2019","unstructured":"Pambrun T, Denis A, Duchateau J, Sacher F, Hocini M, Jais P, Haissaguerre M, Derval N. MARSHALL bundles elimination, Pulmonary veins isolation and Lines completion for ANatomical ablation of persistent atrial fibrillation: MARSHALL-PLAN case series. J Cardiovascular Electrophysiol. 2019;30:7\u201315.","journal-title":"J Cardiovascular Electrophysiol"},{"key":"1842_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.hrthm.2020.12.023","volume":"18","author":"N Derval","year":"2021","unstructured":"Derval N, Duchateau J, Denis A, et al. Marshall bundle elimination, Pulmonary vein isolation, and Line completion for ANatomical ablation of persistent atrial fibrillation (Marshall-PLAN): prospective, single-center study. Heart Rhythm. 2021;18:529\u201337.","journal-title":"Heart Rhythm"},{"key":"1842_CR6","first-page":"661","volume":"66","author":"JS Leyton-Mange","year":"2023","unstructured":"Leyton-Mange JS, Tandon K, Sze EY, Carpenter CM, Sesselberg HW. The Maine vein of Marshall ethanol experience: learning curve and safety. J Interventional Cardiac Electrophysiol: Int J arrhythmias Pacing. 2023;66:661\u201371.","journal-title":"J Interventional Cardiac Electrophysiol: Int J arrhythmias Pacing"},{"key":"1842_CR7","doi-asserted-by":"publisher","first-page":"e010001","DOI":"10.1161\/CIRCEP.121.010001","volume":"14","author":"T Kamakura","year":"2021","unstructured":"Kamakura T, Derval N, Duchateau J, et al. Vein of Marshall ethanol infusion: feasibility, pitfalls, and complications in over 700 patients. Circul Arrhythmia Electrophysiol. 2021;14:e010001.","journal-title":"Circul Arrhythmia Electrophysiol"},{"key":"1842_CR8","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.hrthm.2021.02.009","volume":"18","author":"P Krisai","year":"2021","unstructured":"Krisai P, Pambrun T, Nakatani Y, et al. How to perform ethanol ablation of the vein of Marshall for treatment of atrial fibrillation. Heart Rhythm. 2021;18:1083\u20137.","journal-title":"Heart Rhythm"},{"key":"1842_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.hrcr.2023.01.010","volume":"9","author":"K Motoki","year":"2023","unstructured":"Motoki K, Harada T, Hosokawa S, Hara T, Yamamoto K, Kishi K. Very delayed pericarditis associated with ethanol ablation of the vein of Marshall for treatment of atrial fibrillation. HeartRhythm Case Reports. 2023;9:255\u20137.","journal-title":"HeartRhythm Case Reports"},{"key":"1842_CR10","doi-asserted-by":"publisher","first-page":"e006576","DOI":"10.1161\/CIRCEP.118.006576","volume":"11","author":"A Hussein","year":"2018","unstructured":"Hussein A, Das M, Riva S, et al. Use of ablation index-guided ablation results in high rates of durable pulmonary vein isolation and freedom from arrhythmia in persistent atrial fibrillation patients: the PRAISE study results. Circulation Arrhythmia Electrophysiol. 2018;11:e006576.","journal-title":"Circulation Arrhythmia Electrophysiol"},{"key":"1842_CR11","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.jacep.2017.02.022","volume":"3","author":"M Valderrabano","year":"2017","unstructured":"Valderrabano M, Morales PF, Rodriguez-Manero M, Lloves C, Schurmann PA, Dave AS. The human left atrial venous circulation as a vascular route for atrial pharmacological therapies: effects of ethanol infusion. JACC Clin Electrophysiol. 2017;3:1020\u201332.","journal-title":"JACC Clin Electrophysiol"},{"key":"1842_CR12","doi-asserted-by":"publisher","first-page":"21266","DOI":"10.1016\/j.heliyon.2023.e21266","volume":"9","author":"HD Zhang","year":"2023","unstructured":"Zhang HD, Ding L, Yu FY, Mi LJ, Zhang K, Weng SX, Jiang ZH, Tang M. Angiographic assessment of vein of Marshall in atrial fibrillation: implications for identification and cannulation. Heliyon. 2023;9:21266.","journal-title":"Heliyon"},{"key":"1842_CR13","doi-asserted-by":"crossref","unstructured":"Landra F, Nesti M, Garibaldi S, et al. A proposed index of myocardial staining for vein of Marshall ethanol infusion: an Italian single-center experience. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing Jan 11 2024.","DOI":"10.1007\/s10840-023-01732-4"},{"key":"1842_CR14","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.hrthm.2021.01.005","volume":"18","author":"A Lador","year":"2021","unstructured":"Lador A, Peterson LE, Swarup V, et al. Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: a secondary analysis of the VENUS randomized clinical trial. Heart Rhythm. 2021;18:1045\u201354.","journal-title":"Heart Rhythm"},{"key":"1842_CR15","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jacep.2023.03.021","volume":"9","author":"B Davong","year":"2023","unstructured":"Davong B, Adelino R, Delasnerie H, Albenque JP, Combes N, Cardin C, Voglimacci-Stephanopoli Q, Combes S, Boveda S. Pulsed-field ablation on mitral isthmus in persistent atrial fibrillation: preliminary data on efficacy and safety. JACC Clin Electrophysiol. 2023;9:1070\u201381.","journal-title":"JACC Clin Electrophysiol"},{"key":"1842_CR16","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1016\/j.jacep.2023.04.002","volume":"9","author":"VY Reddy","year":"2023","unstructured":"Reddy VY, Peichl P, Anter E, et al. A focal ablation catheter toggling between radiofrequency and pulsed field energy to treat atrial fibrillation. JACC Clin Electrophysiol. 2023;9:1786\u2013801.","journal-title":"JACC Clin Electrophysiol"},{"key":"1842_CR17","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1161\/CIRCULATIONAHA.122.061497","volume":"146","author":"VY Reddy","year":"2022","unstructured":"Reddy VY, Petru J, Funasako M, Kopriva K, Hala P, Chovanec M, Janotka M, Kralovec S, Neuzil P. Coronary arterial spasm during pulsed field ablation to treat atrial fibrillation. Circulation. 2022;146:1808\u201319.","journal-title":"Circulation"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-024-01842-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-024-01842-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-024-01842-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T02:09:15Z","timestamp":1732846155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-024-01842-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,24]]},"references-count":17,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["1842"],"URL":"https:\/\/doi.org\/10.1007\/s10840-024-01842-7","relation":{},"ISSN":["1572-8595"],"issn-type":[{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,24]]},"assertion":[{"value":"26 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Maine Medical Center Institutional Review Board and performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This is a retrospective study performed by chart review, and as such, informed consent was waived by the Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"J.L.M. has received prior speaking fees from Sanofi Aventis and consulting Fees from Biosense Webster. The remaining authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}